Search results
Showing 6526 to 6540 of 7707 results
This evidence summary has been updated and replaced by NICE advice ESNM26.
This evidence summary has been withdrawn because the product is no longer available in the UK.
Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration (ESNM12)
This evidence summary has been withdrawn because the product is no longer available in the UK.
Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)
This evidence summary has been updated and replaced by NICE guideline NG117.
Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)
This evidence summary has been updated and replaced by NICE guideline NG101.
Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)
This evidence summary has been updated and replaced by NICE guideline 115.
This evidence summary has been withdrawn because the product is no longer available in the UK.
This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.
This evidence summary has been withdrawn as the licence of ingenol mebutate gel has been suspended.
This evidence summary has been replaced by ESNM48
Irritable bowel syndrome with constipation in adults: linaclotide (ESNM16)
This evidence summary has been updated and replaced by NICE guideline CG61.
Partial-onset seizures in epilepsy: zonisamide as monotherapy (ESNM17)
This evidence summary has been updated and replaced by NICE guideline NG217.
Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil (ESNM18)
This evidence summary has been updated and replaced by NICE guideline CG97.
This evidence summary has been updated and replaced by NICE guideline NG87.
Idiopathic overactive bladder syndrome: botulinum toxin A (ESNM2)
This evidence summary has been replaced by NICE guideline CG171.